Abstract
The discovery that variants in the melatonin receptor 2 (MTNR1B) gene were associated with glucose levels, insulin secretion, and risk for type 2 diabetes (T2D) in genome-wide association studies (GWAS) reinforced the previously suggested link between glucose homeostasis and circadian rhythmicity. Diurnal secretion of melatonin has reported to be altered in people with diabetes and rodent models of T2D. The proposed underlying mechanisms by which altered melatonin signaling could predispose to progression to T2D and gestational diabetes mellitus (GDM) involve altered expression of MTNR1B in pancreatic beta cells, leading to impaired insulin secretion, consequent increased fasting glucose concentrations, and eventually overt T2D. Thus blocking the inhibition of insulin secretion may have potential clinical implications, and these effects could be more pronounced in individuals carrying risk genotypes. Finally, given that melatonin could emerge as an attractive treatment for a variety of conditions including pregnancies associated with GDM, preeclampsia, and intrauterine growth retardation, pharmacogenetic studies are warranted to determine treatment response and side effects according to genotype.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Diabetes Association (2014a) Standards of medical care in diabetes--2014. Diabetes Care 37(Suppl 1):S14–S80. doi:10.2337/dc14-S014
American Diabetes Association (2014b) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–S90. doi:10.2337/dc14-S081
Arendt J (2006) Does melatonin improve sleep? Efficacy of melatonin. BMJ 332:550. doi:10.1136/bmj.332.7540.550
Arendt J, Skene DJ, Middleton B et al (1997) Efficacy of melatonin treatment in jet lag, shift work, and blindness. J Biol Rhythms 12:604–617
Axelrod J, Weissbach H (1960) Enzymatic O-methylation of N-acetylserotonin to melatonin. Science 131:1312
Bach AG, Wolgast S, Mühlbauer E, Peschke E (2005) Melatonin stimulates inositol-1,4,5-trisphosphate and Ca2+ release from INS1 insulinoma cells. J Pineal Res 39:316–323. doi:10.1111/j.1600-079X.2005.00253.x
Bailey CJ, Atkins TW, Matty AJ (1974) Melatonin inhibition of insulin secretion in the rat and mouse. Horm Res 5:21–28
Barker A, Sharp SJ, Timpson NJ et al (2011) Association of genetic Loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes 60:1805–1812. doi:10.2337/db10-1575
Barr ELM, Zimmet PZ, Welborn TA et al (2007) Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116:151–157. doi:10.1161/CIRCULATIONAHA.106.685628
Bass J, Takahashi JS (2010) Circadian integration of metabolism and energetics. Science 330:1349–1354. doi:10.1126/science.1195027
Below JE, Gamazon ER, Morrison JV et al (2011) Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals. Diabetologia 54:2047–2055. doi:10.1007/s00125-011-2188-3
Bonnefond A, Clément N, Fawcett K et al (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44:297–301. doi:10.1038/ng.1053
Bouatia-Naji N, Rocheleau G, Van Lommel L et al (2008) A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 320:1085–1088. doi:10.1126/science.1156849
Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C et al (2009) A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 41:89–94. doi:10.1038/ng.277
Boutin JA, Audinot V, Ferry G, Delagrange P (2005) Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 26:412–419. doi:10.1016/j.tips.2005.06.006
Brydon L, Petit L, Delagrange P et al (2001) Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 142:4264–4271. doi:10.1210/endo.142.10.8423
Buxton OM, Cain SW, O’Connor SP et al (2012) Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med 4:129ra43. doi:10.1126/scitranslmed.3003200
Chambers JC, Zhang W, Zabaneh D et al (2009) Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes 58:2703–2708. doi:10.2337/db08-1805
Chen W-M, Erdos MR, Jackson AU et al (2008) Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 118:2620–2628. doi:10.1172/JCI34566
Chen C-Q, Fichna J, Bashashati M et al (2011) Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol 17:3888–3898. doi:10.3748/wjg.v17.i34.3888
Cho H, Zhao X, Hatori M et al (2012) Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature 485:123–127. doi:10.1038/nature11048
Dubocovich ML, Markowska M (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101–110. doi:10.1385/ENDO:27:2:101
Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105–116. doi:10.1038/ng.520
Evans JA, Davidson AJ (2013) Health consequences of circadian disruption in humans and animal models. Prog Mol Biol Transl Sci 119:283–323. doi:10.1016/B978-0-12-396971-2.00010-5
Florez JC, Jablonski KA, McAteer JB et al (2012) Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. PLoS ONE 7, e44424. doi:10.1371/journal.pone.0044424
Garaulet M, Corbalán MD, Madrid JA et al (2010) CLOCK gene is implicated in weight reduction in obese patients participating in a dietary programme based on the Mediterranean diet. Int J Obes 34:516–523. doi:10.1038/ijo.2009.255
Garaulet M, Smith CE, Gomez-Abellán P et al (2013) REV-ERB-ALPHA circadian gene variant associates with obesity in two independent populations: Mediterranean and North American. Mol Nutr Food Res. doi:10.1002/mnfr.201300361
Goumidi L, Grechez A, Dumont J et al (2013) Impact of REV-ERB alpha gene polymorphisms on obesity phenotypes in adult and adolescent samples. Int J Obes 37:666–672. doi:10.1038/ijo.2012.117
Ha E, Yim S-V, Chung J-H et al (2006) Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res 41:67–72. doi:10.1111/j.1600-079X.2006.00334.x
Hardeland R (2005) Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27:119–130
Hoffman RA, Reiter RJ (1965) Pineal gland: influence on gonads of male hamsters. Science 148:1609–1611
Huopio H, Cederberg H, Vangipurapu J et al (2013) Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 169:291–297. doi:10.1530/EJE-13-0286
Illig T, Gieger C, Zhai G et al (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42:137–141. doi:10.1038/ng.507
Illnerová H, Sumová A (1997) Photic entrainment of the mammalian rhythm in melatonin production. J Biol Rhythms 12:547–555
Jassal B, Jupe S, Caudy M et al (2010) The systematic annotation of the three main GPCR families in Reactome. Database (Oxford) 2010:baq018. doi:10.1093/database/baq018
Jockers R, Maurice P, Boutin JA, Delagrange P (2008) Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? Br J Pharmacol 154:1182–1195. doi:10.1038/bjp.2008.184
Jonsson A, Ladenvall C, Ahluwalia TS et al (2013) Effects of common genetic variants associated with type 2 diabetes and glycemic traits on α- and β-cell function and insulin action in humans. Diabetes 62:2978–2983. doi:10.2337/db12-1627
Kan MY, Zhou DZ, Zhang D et al (2010) Two susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort. Diabet Med 27:598–602. doi:10.1111/j.1464-5491.2010.02975.x
Karamitri A, Renault N, Clement N et al (2013) Minireview: toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes. Mol Endocrinol 27:1217–1233. doi:10.1210/me.2013-1101
Kelly MA, Rees SD, Hydrie MZI et al (2012) Circadian gene variants and susceptibility to type 2 diabetes: a pilot study. PLoS ONE 7, e32670. doi:10.1371/journal.pone.0032670
Kemp DM, Ubeda M, Habener JF (2002) Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol 191:157–166
Kennaway DJ, Voultsios A, Varcoe TJ, Moyer RW (2002) Melatonin in mice: rhythms, response to light, adrenergic stimulation, and metabolism. Am J Physiol Regul Integr Comp Physiol 282:R358–R365. doi:10.1152/ajpregu.00360.2001
Kim YJ, Go MJ, Hu C et al (2011) Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat Genet 43:990–995. doi:10.1038/ng.939
Kivimäki M, Batty GD, Hublin C (2011) Shift work as a risk factor for future type 2 diabetes: evidence, mechanisms, implications, and future research directions. PLoS Med 8, e1001138. doi:10.1371/journal.pmed.1001138
Klerman EB, Shanahan TL, Brotman DJ et al (2002) Photic resetting of the human circadian pacemaker in the absence of conscious vision. J Biol Rhythms 17:548–555
Korkmaz A, Rosales-Corral S, Reiter RJ (2012) Gene regulation by melatonin linked to epigenetic phenomena. Gene 503:1–11. doi:10.1016/j.gene.2012.04.040
Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21–80. doi:10.1016/j.pharmthera.2004.05.002
Kvetnoy I, Sandvik AK, Waldum HL (1997) The diffuse neuroendocrine system and extrapineal melatonin. J Mol Endocrinol 18:1–3
Kwak SH, Kim S-H, Cho YM et al (2012) A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 61:531–541. doi:10.2337/db11-1034
Lamia KA, Evans RM (2010) Metabolism: tick, tock, a beta-cell clock. Nature 466:571–572. doi:10.1038/466571a
Leproult R, Holmbäck U, Van Cauter E (2014) Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. doi:10.2337/db13-1546
Liao S, Liu Y, Tan Y et al (2012) Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women. PLoS ONE 7, e40113. doi:10.1371/journal.pone.0040113
Ling Y, Li X, Gu Q et al (2011) A common polymorphism rs3781637 in MTNR1B is associated with type 2 diabetes and lipids levels in Han Chinese individuals. Cardiovasc Diabetol 10:27. doi:10.1186/1475-2840-10-27
Liu C, Wu Y, Li H et al (2010) MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC Med Genet 11:59. doi:10.1186/1471-2350-11-59
Lyssenko V, Nagorny CLF, Erdos MR et al (2009) Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 41:82–88. doi:10.1038/ng.288
Marcheva B, Ramsey KM, Buhr ED et al (2010) Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466:627–631. doi:10.1038/nature09253
Masana MI, Doolen S, Ersahin C et al (2002) MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302:1295–1302
McMullan CJ, Schernhammer ES, Rimm EB et al (2013) Melatonin secretion and the incidence of type 2 diabetes. JAMA 309:1388–1396. doi:10.1001/jama.2013.2710
Mirzaei K, Xu M, Qi Q et al (2014) Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial. Am J Clin Nutr 99:392–399. doi:10.3945/ajcn.113.072066
Mohawk JA, Green CB, Takahashi JS (2012) Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 35:445–462. doi:10.1146/annurev-neuro-060909-153128
Monk TH, Buysse DJ (2013) Exposure to shift work as a risk factor for diabetes. J Biol Rhythms 28:356–359. doi:10.1177/0748730413506557
Ohshige T, Iwata M, Omori S et al (2011) Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese. PLoS ONE 6, e26911. doi:10.1371/journal.pone.0026911
Okatani Y, Okamoto K, Hayashi K et al (1998) Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 25:129–134
Pan A, Schernhammer ES, Sun Q, Hu FB (2011) Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med 8, e1001141. doi:10.1371/journal.pmed.1001141
Panda S, Antoch MP, Miller BH et al (2002) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109:307–320
Peschke E (2008) Melatonin, endocrine pancreas and diabetes. J Pineal Res 44:26–40. doi:10.1111/j.1600-079X.2007.00519.x
Peschke E, Mühlbauer E, Musshoff U et al (2002) Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J Pineal Res 33:63–71
Peschke E, Bach AG, Mühlbauer E (2006a) Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res 40:184–191. doi:10.1111/j.1600-079X.2005.00297.x
Peschke E, Frese T, Chankiewitz E et al (2006b) Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 40:135–143. doi:10.1111/j.1600-079X.2005.00287.x
Pilia G, Chen W-M, Scuteri A et al (2006) Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2, e132. doi:10.1371/journal.pgen.0020132
Poon AM, Choy EH, Pang SF (2001) Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes. Biol Signals Recept 10:367–379
Prokopenko I, Langenberg C, Florez JC et al (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41:77–81. doi:10.1038/ng.290
Prokopenko I, Poon W, Mägi R et al (2014) A central role for GRB10 in regulation of islet function in man. PLoS Genet 10, e1004235. doi:10.1371/journal.pgen.1004235
Ramos E, Chen G, Shriner D et al (2011) Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans. Diabetologia 54:783–788. doi:10.1007/s00125-010-2002-7
Ramracheya RD, Muller DS, Squires PE et al (2008) Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 44:273–279. doi:10.1111/j.1600-079X.2007.00523.x
Rasmussen-Torvik LJ, Guo X, Bowden DW et al (2012) Fasting glucose GWAS candidate region analysis across ethnic groups in the Multiethnic Study of Atherosclerosis (MESA). Genet Epidemiol 36:384–391. doi:10.1002/gepi.21632
Reiter RJ, Tan DX, Korkmaz A, Rosales-Corral SA (2014) Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum Reprod Update 20:293–307. doi:10.1093/humupd/dmt054
Renström F, Shungin D, Johansson I et al (2011) Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: ten-year follow-up of the GLACIER study. Diabetes 60:345–354. doi:10.2337/db10-0933
Reppert SM, Weaver DR, Ebisawa T (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177–1185
Reppert SM, Godson C, Mahle CD et al (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 92:8734–8738
Rönn T, Wen J, Yang Z et al (2009) A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia 52:830–833. doi:10.1007/s00125-009-1297-8
Sadacca LA, Lamia KA, deLemos AS et al (2011) An intrinsic circadian clock of the pancreas is required for normal insulin release and glucose homeostasis in mice. Diabetologia 54:120–124. doi:10.1007/s00125-010-1920-8
Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA (2009) Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA 106:4453–4458. doi:10.1073/pnas.0808180106
Scott RA, Lagou V, Welch RP et al (2012) Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44:991–1005. doi:10.1038/ng.2385
Shi S, Ansari TS, McGuinness OP et al (2013) Circadian disruption leads to insulin resistance and obesity. Curr Biol 23:372–381. doi:10.1016/j.cub.2013.01.048
Simonis-Bik AM, Nijpels G, van Haeften TW et al (2010) Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 59:293–301. doi:10.2337/db09-1048
Sparsø T, Bonnefond A, Andersson E et al (2009) G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans. Diabetes 58:1450–1456. doi:10.2337/db08-1660
Stamenkovic JA, Olsson AH, Nagorny CL et al (2012) Regulation of core clock genes in human islets. Metabolism 61:978–985. doi:10.1016/j.metabol.2011.11.013
Stumpf I, Mühlbauer E, Peschke E (2008) Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J Pineal Res 45:318–327. doi:10.1111/j.1600-079X.2008.00593.x
Stumpf I, Bazwinsky I, Peschke E (2009) Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells. J Pineal Res 46:140–147. doi:10.1111/j.1600-079X.2008.00638.x
Takahashi JS, Hong H-K, Ko CH, McDearmon EL (2008) The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 9:764–775. doi:10.1038/nrg2430
Takeuchi F, Katsuya T, Chakrewarthy S et al (2010) Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia 53:299–308. doi:10.1007/s00125-009-1595-1
Taneera J, Lang S, Sharma A et al (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16:122–134. doi:10.1016/j.cmet.2012.06.006
Tirosh A, Shai I, Tekes-Manova D et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454–1462. doi:10.1056/NEJMoa050080
Turek FW, Joshu C, Kohsaka A et al (2005) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308:1043–1045. doi:10.1126/science.1108750
Vangipurapu J, Stančáková A, Pihlajamäki J et al (2011) Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men. Diabetologia 54:563–571. doi:10.1007/s00125-010-1977-4
Venkatakrishnan AJ, Deupi X, Lebon G et al (2013) Molecular signatures of G-protein-coupled receptors. Nature 494:185–194. doi:10.1038/nature11896
Vlassi M, Gazouli M, Paltoglou G et al (2012) The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population. Hormones (Athens) 11:70–76
Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589. doi:10.1038/ng.609
Vyas MV, Garg AX, Iansavichus AV et al (2012) Shift work and vascular events: systematic review and meta-analysis. BMJ 345, e4800
Walford GA, Green T, Neale B et al (2012) Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia 55:331–339. doi:10.1007/s00125-011-2353-8
Wang Y, Nie M, Li W et al (2011) Association of six single nucleotide polymorphisms with gestational diabetes mellitus in a Chinese population. PLoS ONE 6, e26953. doi:10.1371/journal.pone.0026953
Wang H, Liu L, Zhao J et al (2013) Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS ONE 8, e67665. doi:10.1371/journal.pone.0067665
Watanabe RM, Valle T, Hauser ER et al (1999) Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 49:159–168, doi: 22865
Weitzman ED, Fukushima D, Nogeire C et al (1971) Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33:14–22. doi:10.1210/jcem-33-1-14
Woon PY, Kaisaki PJ, Bragança J et al (2007) Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA 104:14412–14417. doi:10.1073/pnas.0703247104
World Health Organization (2013) http://www.who.int/mediacentre/factsheets/fs312/. Fact sheet N°312
Xia Q, Chen Z-X, Wang Y-C et al (2012) Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis. PLoS ONE 7, e50107. doi:10.1371/journal.pone.0050107
Zhao Q, Xiao J, He J et al (2014) Cross-sectional and longitudinal replication analyses of genome-wide association Loci of type 2 diabetes in han chinese. PLoS ONE 9, e91790. doi:10.1371/journal.pone.0091790
Zhdanova IV, Wurtman RJ (1997) Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms 12:644–650
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bonnefond, A., Lyssenko, V. (2016). From Association to Function: MTNR1B . In: Florez, J. (eds) The Genetics of Type 2 Diabetes and Related Traits. Springer, Cham. https://doi.org/10.1007/978-3-319-01574-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-01574-3_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-01573-6
Online ISBN: 978-3-319-01574-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)